Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Trimel provides update on intranasal gel for female anorgasmia

Feb. 16, 2012

Columbia Laboratories transfers progesterone vaginal gel NDA

Feb. 15, 2012

New phase III data support once-weekly exenatide use for diabetes type 2

Feb. 15, 2012

Amarin gives update on FDA's review of AMR-101 NDA

Feb. 15, 2012

Amylin Pharmaceuticals launches Bydureon in U.S.

Feb. 14, 2012

Karo Bio discontinues development of eprotirome

Feb. 14, 2012

New bile acid GPBA receptor agonists developed at Roche

Feb. 14, 2012

Antisense Therapeutics provides update on second-generation product

Feb. 14, 2012

Zealand Pharma to receive milestone payment following completion of GetGoal program

Feb. 13, 2012

DMC recommends LibiGel safety study continue as planned

Feb. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...